उत्पाद विवरण
Bufatas IV Injection is a potent therapeutic option designed to combat various blood cancers, including acute lymphocytic leukemia, acute and chronic myeloid leukemia, Hodgkins disease, non-Hodgkins lymphoma, multiple myeloma, and myelodysplastic syndromes. Administered in conjunction with other chemotherapy agents, this injection plays a critical role in the treatment process, particularly during hematopoietic progenitor cell transplantation (HPCT). The mechanism of Bufatas involves targeting and damaging the genetic structures of cancer cellsspecifically their DNA and RNAthereby inhibiting their growth and proliferation. Patients should be aware of potential side effects, including increased susceptibility to infections and blood disorders, which necessitate careful monitoring throughout treatment. As a vital component of cancer management, Bufatas IV Injection underscores the importance of a comprehensive approach to therapy, ensuring patients receive the best possible care. Always consult healthcare professionals for personalized guidance and to understand the full range of benefits and risks associated with this medication. Its effectiveness, when used appropriately, can significantly impact treatment outcomes for those battling these challenging conditions.
Send Email 
जांच भेजें
जांच भेजें
एसएमएस भेजें
English
Spanish
French
German
Italian
Chinese (Simplified)
Japanese
Korean
Arabic
Portuguese